HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lillian D Traber Selected Research

Smoke

4/2014No correlation between initial arterial carboxyhemoglobin level and degree of lung injury following ovine burn and smoke inhalation.
12/2013Antithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injury.
1/2013Antithrombin attenuates myocardial dysfunction and reverses systemic fluid accumulation following burn and smoke inhalation injury: a randomized, controlled, experimental study.
12/2012Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model.
12/2012γ-tocopherol nebulization decreases oxidative stress, arginase activity, and collagen deposition after burn and smoke inhalation in the ovine model.
11/2012Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.
11/2012Administration of a peroxynitrite decomposition catalyst into the bronchial artery attenuates pulmonary dysfunction after smoke inhalation and burn injury in sheep.
9/2012Development of a long-term ovine model of cutaneous burn and smoke inhalation injury and the effects of early excision and skin autografting.
7/2012Assessment of combined muscarinic antagonist and fibrinolytic therapy for inhalation injury.
4/2012Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lillian D Traber Research Topics

Disease

48Burns
05/2014 - 11/2002
45Acute Lung Injury
12/2013 - 09/2002
35Smoke Inhalation Injury
04/2014 - 11/2002
31Sepsis (Septicemia)
07/2014 - 09/2002
16Airway Obstruction (Choking)
12/2013 - 09/2003
12Lung Injury
04/2014 - 03/2003
12Edema
12/2013 - 09/2002
12Pulmonary Edema
12/2012 - 07/2003
9Septic Shock (Toxic Shock Syndrome)
11/2012 - 07/2003
7Pneumonia (Pneumonitis)
07/2014 - 09/2002
6Wounds and Injuries (Trauma)
05/2014 - 11/2005
5Inflammation
01/2013 - 02/2003
4Stroke (Strokes)
01/2013 - 11/2009
4Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2012 - 04/2008
3Fistula
04/2008 - 12/2004
2Hemorrhage
12/2013 - 09/2006
2Hyperemia
04/2011 - 07/2009
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
02/2011 - 11/2003
1Left Ventricular Dysfunction
11/2012
1Cicatrix (Scar)
09/2012
1Abscess
09/2012
1Respiratory Insufficiency (Respiratory Failure)
05/2012
1Infection
04/2012

Drug/Important Bio-Agent (IBA)

56SmokeIBA
04/2014 - 09/2002
21Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 11/2003
16salicylhydroxamic acid (SHAM)IBA
04/2014 - 05/2006
93-nitrotyrosineIBA
11/2012 - 05/2006
8Peroxidase (Myeloperoxidase)IBA
01/2013 - 08/2008
7Nitric Oxide Synthase (NO Synthase)IBA
12/2013 - 04/2003
6Peroxynitrous Acid (Peroxynitrite)IBA
11/2012 - 05/2006
6Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2011 - 05/2006
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2012 - 02/2004
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 01/2009
5Malondialdehyde (Propanedial)IBA
02/2012 - 02/2011
5tranilast (N 5')IBA
10/2011 - 03/2003
5OxygenIBA
06/2011 - 02/2005
5Superoxides (Superoxide)IBA
02/2011 - 02/2005
5Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
12/2010 - 04/2008
4Reactive Nitrogen SpeciesIBA
12/2012 - 02/2011
4Poly Adenosine Diphosphate RiboseIBA
06/2011 - 07/2003
4Protein Isoforms (Isoforms)IBA
06/2011 - 02/2006
4Halothane (Fluothane)FDA Link
05/2011 - 12/2007
4Heparin (Liquaemin)FDA LinkGeneric
02/2008 - 09/2002
3Arginine Vasopressin (Argipressin)IBA
07/2014 - 02/2011
3CollagenIBA
12/2012 - 03/2011
3ArginaseIBA
12/2012 - 03/2011
3CytokinesIBA
04/2012 - 11/2005
3drotrecogin alfa activated (Xigris)FDA Link
02/2012 - 09/2006
3Protein CIBA
02/2012 - 09/2006
3Vitamin EFDA LinkGeneric
12/2010 - 01/2006
3NitrogenIBA
01/2010 - 07/2007
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
07/2014 - 06/2012
2CarboxyhemoglobinIBA
04/2014 - 05/2011
2Interleukin-6 (Interleukin 6)IBA
01/2013 - 05/2012
2Vasopressins (Vasopressin)IBA
11/2012 - 06/2012
2Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2012 - 04/2003
2Messenger RNA (mRNA)IBA
11/2012 - 08/2008
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
07/2012 - 12/2010
2tiotropium (Spiriva)FDA Link
07/2012 - 12/2010
2Ceftazidime (Fortum)FDA LinkGeneric
02/2012 - 07/2007
27-nitroindazoleIBA
12/2011 - 04/2008
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2011 - 03/2011
2IsofluraneFDA LinkGeneric
06/2011 - 03/2006
2Adenosine Diphosphate (ADP)IBA
06/2011 - 01/2010
2GasesIBA
11/2009 - 05/2006
2Interleukin-2 (IL2)IBA
12/2008 - 11/2003
2AnticoagulantsIBA
02/2008 - 12/2007
2Arginine (L-Arginine)FDA Link
10/2007 - 04/2003
2alpha-TocopherolFDA Link
03/2006 - 01/2006
1HormonesIBA
07/2014
1Oil AIBA
05/2014
1Syndecan-4IBA
12/2013
1Antithrombin IIIIBA
12/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013
1Protein Kinases (Protein Kinase)IBA
01/2013
1N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA
12/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2012
1dimethylarginineIBA
12/2012
1Angiopoietin-2IBA
11/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
07/2012
1von Willebrand FactorIBA
06/2012
1Ethanol (Ethyl Alcohol)IBA
04/2012
1NeuropeptidesIBA
12/2011
1NitritesIBA
11/2011
1NitratesIBA
11/2011
1Captopril (Capoten)FDA LinkGeneric
10/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2011

Therapy/Procedure

9Anesthesia
12/2012 - 01/2006
2Tracheostomy
10/2011 - 06/2006
2Ligation
05/2011 - 04/2010
2Mechanical Ventilators (Ventilator)
03/2006 - 01/2006
2Positive-Pressure Respiration (PEEP)
03/2006 - 01/2006
1Lasers (Laser)
05/2014
1Transplants (Transplant)
05/2014
1Injections
07/2013
1Microspheres (Microsphere)
07/2013
1Intravenous Infusions
01/2013
1Autologous Transplantation
09/2012
1Skin Transplantation (Skin Grafting)
09/2012